Vicki Lyons, MD
Payments from drug & device makers
Across 155 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$856
- AstraZeneca$530
- Sanofi$397
- Grifols USA, LLC$317
- Regeneron Healthcare Solutions, Inc.$167
- Kaleo, Inc.$157
- plus $837 from 18 others
What the payments were for
- Food & beverage$3,23499%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 47 | $856 |
| AstraZeneca | 25 | $530 |
| Sanofi | 14 | $397 |
| Grifols USA, LLC | 14 | $317 |
| Regeneron Healthcare Solutions, Inc. | 8 | $167 |
| Kaleo, Inc. | 9 | $157 |
| Xoran Technologies LLC | 2 | $105 |
| Novartis | 4 | $77 |
| Aimmune Therapeutics, Inc. | 4 | $77 |
| CSL Behring | 4 | $77 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $73 |
| Genentech USA, Inc. | 4 | $68 |
| Amgen | 3 | $60 |
| Optinose US, Inc. | 2 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Galderma Laboratories, L.p. | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Pfizer | 1 | $20 |
| Pharming Healthcare, Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
| Octapharma USA, Inc. | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$122
- AIRSUPRA$115
- DUPIXENT$109
How this compares
Too few allergy providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Ogden
- Timothy SullivanOgden$7K
- Douglas JonesLayton$1.4M
- Jan Bernhisel-BroadbentMurray$190K
- Jordan PittFarmington$6K
- Robert SilgeSalt Lake City$521
- Scott DicksonLogan$73
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.